Home > News Release > News Archive > 2010 > NIMS signed MOU with the Heart Research Center, Chonnam National University Hospital, Korea

NIMS signed MOU with the Heart Research Center, Chonnam National University Hospital, Korea

2010.03.11
(2010.04.01 Update)


The NIMS Biomaterials Center signed a memorandum of understanding (MOU) on research cooperation with the Heart Research Center, Chonnam National University Hospital, of South Korea.

"From left: Dr.Mitsuhiro Ebara (NIMS, Senior Researcher), Dr.Takao Aoyanagi (NIMS, Coordinating Director), Prof. Young-Jin Kim (Chonnam National University Hospital, General Director), Prof. Myung Ho Jeong (Chonnam National University Hospital, Director of Heart Research Center)" Image

From left: Dr.Mitsuhiro Ebara (NIMS, Senior Researcher), Dr.Takao Aoyanagi (NIMS, Coordinating Director), Prof. Young-Jin Kim (Chonnam National University Hospital, General Director), Prof. Myung Ho Jeong (Chonnam National University Hospital, Director of Heart Research Center)



(March 11, 2010) The NIMS Biomaterials Center signed a memorandum of understanding (MOU) on research cooperation and joint research in connection with “Development of New Materials for Treatment of Heart Disease” with the Heart Research Center, Chonnam National University Hospital, of South Korea. Under this agreement, the Biomaterials Center and Heart Research Center plan to create a system for exchanging researchers, information and research results, and conduct joint research.

Chonnam National University Hospital performs more than 1000 coronary angioplasty procedures each year and boasts a success rate of 97.8%. As a key hospital in the Chonnam region, the hospital has recently constructed new facilities, including a Cancer Center and a Diagnostic Imaging Center, among others.

Researchers from NIMS and Chonnam National University Hospital already have a record of obtaining international grants, such as bilateral exchange projects, etc. In the future, the two institutions plan to carry out joint research on drug delivery systems for the treatment of heart disease, gene therapy, and next-generation medical materials for coronary angioplasty.